Impact of Renal Failure on the Tumor Markers of Mesothelioma, N-ERC/Mesothelin and Osteopontin

被引:0
作者
Shiomi, Kazu [1 ]
Shiomi, Satoko [2 ]
Ishinaga, Yuji [2 ]
Sakuraba, Motoki [1 ]
Hagiwara, Yoshiaki [3 ]
Miyashita, Kazuya [3 ]
Maeda, Masahiro [3 ]
Suzuki, Kenji [1 ]
Takahashi, Kazuhisa [4 ]
Hino, Okio [5 ]
机构
[1] Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Tokyo 113, Japan
[2] Shouwakai Hosp, Dept Internal Med, Tokyo, Japan
[3] Immunobiol Labs Co Ltd, Gunma, Japan
[4] Juntendo Univ, Sch Med, Dept Resp Med, Tokyo 113, Japan
[5] Juntendo Univ, Sch Med, Dept Pathol & Oncol, Tokyo 113, Japan
关键词
Renal failure; mesothelioma; tumor markers; N-ERC/mesothelin; osteopontin; ASBESTOS-RELATED MESOTHELIOMA; LINKED-IMMUNOSORBENT-ASSAY; HEMODIALYSIS-PATIENTS; RAT ERC/MESOTHELIN; ELISA SYSTEM; ANTIGEN; ESTABLISHMENT; CANCER;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Knowledge of the characteristics and effective use of tumour markers for mesothelioma is essential for early-stage diagnosis of mesothelioma. We examined whether renal dysfunction influences blood concentrations of promising new tumour markers, N-ERC/mesothelin (N-ERC) and osteopontin (OPN), to an important degree. Patients and Methods: Levels of serum N-ERC and plasma OPN in 32 patients with chronic renal dysfunction, 22 of whom were on hemodialysis (CKD group), and 102 healthy volunteers were measured. Results: Serum concentrations of N-ERC and plasma concentrations of OPN in the CKD group were significantly higher than those in volunteers, regardless of diabetes status and age. Blood concentrations of these markers increased as renal function decreased. Conclusion: N-ERC and OPN concentrations are significantly influenced by renal function. Therefore, the extent of renal failure must be considered when inferring the existence of tumours and chemotherapeutic response from the values of these markers in routine practice.
引用
收藏
页码:1427 / 1430
页数:4
相关论文
共 23 条
  • [1] Abnormal renal function as a cause of false-positive biochemical screening for Down's syndrome
    Cararach, V
    Casals, E
    Martinez, S
    Carmona, F
    Aibar, C
    Quinto, LI
    Alonso, P
    Fortuny, A
    [J]. LANCET, 1997, 350 (9087) : 1295 - 1295
  • [2] TUMOR-MARKERS IN CHRONIC-RENAL-FAILURE AND HEMODIALYSIS-PATIENTS
    CASES, A
    FILELLA, X
    MOLINA, R
    BALLESTA, AM
    LOPEZPEDRET, J
    REVERT, L
    [J]. NEPHRON, 1991, 57 (02): : 183 - 186
  • [3] Do renal failure and hemodialysis have any effect on the elimination of free and total prostate-specific antigen?
    Danisman, A
    Kiliç, S
    Kukul, E
    Yakupoglu, G
    Güntekin, E
    Baykara, M
    Sevük, M
    [J]. EUROPEAN UROLOGY, 2000, 37 (05) : 579 - 581
  • [4] TUMOR-MARKERS IN CHRONIC-RENAL-FAILURE AND HEMODIALYSIS-PATIENTS
    ESKIOCAK, S
    DORTOK, H
    ALVUR, M
    CENGIZ, K
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (07) : 1256 - 1256
  • [5] FILELLA X, 1990, International Journal of Biological Markers, V5, P85
  • [6] Establishment of a novel specific ELISA system for rat N- and C-ERC/mesothelin. Rat ERC/mesothelin in the body fluids of mice bearing mesothelioma
    Hagiwara, Yoshiaki
    Hamada, Yukiko
    Kuwahara, Maki
    Maeda, Masahiro
    Segawa, Tatsuya
    Ishikawa, Kiyoshi
    Hino, Okio
    [J]. CANCER SCIENCE, 2008, 99 (04) : 666 - 670
  • [7] Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer
    Hassan, R
    Remaley, AT
    Sampson, ML
    Zhang, JL
    Cox, DD
    Pingpank, J
    Alexander, R
    Willingham, M
    Pastan, I
    Onda, M
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (02) : 447 - 453
  • [8] Multistep renal carcinogenesis in the eker (Tsc 2 gene mutant) rat model
    Hino, O
    [J]. CURRENT MOLECULAR MEDICINE, 2004, 4 (08) : 807 - 811
  • [9] Hino Okio, 2008, Environmental Health and Preventive Medicine, V13, P71, DOI 10.1007/s12199-007-0014-9
  • [10] Blood tests for asbestos-related mesothelioma
    Maeda, Masahiro
    Hino, Okio
    [J]. ONCOLOGY, 2006, 71 (1-2) : 26 - 31